The impact of proactive versus reactive drug monitoring of infliximab on treatment outcomes in patients with crohn's disease.

Yue ZhangWenyu JiangChenjing XuJiahui TianJie ChenHong-Jie Zhang

Published in: Scandinavian journal of gastroenterology (2023)

Proactive TDM of IFX plays a more crucial role in timely adjustment of treatment strategies and maintenance of effective concentrations, thereby contributing to the outcomes for CD patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
weight loss
patient reported